Feng Gao, MD, PhD

Medical School Department Biostatistics
Research Program Prevention and Control
Feng Gao

Researcher Background

Primary Academic Title

Professor of Surgery, Division of Public Health Sciences, WashU Medicine

Education

  • 1990: MD, Preventive Medicine, Beijing Medical University, Beijing, China
  • 1996: MPH, Medical Statistics, Beijing Medical University, Beijing, China
  • 2002: MS/PhD, Biostatistics, Emory University, Atlanta, GA

Research & Selected Publications

Research Interest

Development of mathematical/statistical methodology for survival data and longitudinal data. Also, statistical design and data analysis for cancer-related studies.

Research Publications

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Authors:

Kong T, Mabry A, Highkin M, one or more additional authors omitted Gao F, one or more additional authors omitted Ma CX

Journal & Year:

Nat Commun • 2026

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation.
Authors:

Abboud R, Schroeder MA, Rettig MP, one or more additional authors omitted Gao F, one or more additional authors omitted DiPersio JF

Journal & Year:

Blood • 2025

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.
Authors:

Jacoby MA, Duncavage ED, Khanna A, one or more additional authors omitted Gao F, one or more additional authors omitted Walter MJ

Journal & Year:

Leukemia • 2025

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Authors:

Zhang X, Goedegebuure SP, Chen MY, one or more additional authors omitted Gao F, one or more additional authors omitted Gillanders WE

Journal & Year:

Genome Med • 2024

Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids.
Authors:

Suvilesh KN, Manjunath Y, Nussbaum YI, one or more additional authors omitted Gao F, one or more additional authors omitted Kaifi JT

Journal & Year:

Clin Cancer Res • 2024

Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation.
Authors:

Foltz JA, Tran J, Wong P, one or more additional authors omitted Gao F, one or more additional authors omitted Fehniger TA

Journal & Year:

Sci Immunol • 2024

Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia.
Authors:

Johansson KB, Zimmerman MS, Dmytrenko IV, Gao F , Link DC

Journal & Year:

Leukemia • 2023

An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
Authors:

Xiang J, Devenport JM, Carter AJ, one or more additional authors omitted Gao F, one or more additional authors omitted DiPersio JF

Journal & Year:

Leukemia • 2023